E. Kucuksayan Et Al. , "New combination strategy of doxorubicin and epoxomicin in biocompatibility: Biodegradable polymeric nanoparticles increase apoptosis in breast cancer cells," European Biotechnology Congress , vol.256, Dubrovnik, Croatia, 2017
Kucuksayan, E. Et Al. 2017. New combination strategy of doxorubicin and epoxomicin in biocompatibility: Biodegradable polymeric nanoparticles increase apoptosis in breast cancer cells. European Biotechnology Congress , (Dubrovnik, Croatia).
Kucuksayan, E., BOZKURT, F., Ozben, T., Cicek, P. K., Hanikoglu, A., & YILMAZ, M. T., (2017). New combination strategy of doxorubicin and epoxomicin in biocompatibility: Biodegradable polymeric nanoparticles increase apoptosis in breast cancer cells . European Biotechnology Congress, Dubrovnik, Croatia
Kucuksayan, ERTAN Et Al. "New combination strategy of doxorubicin and epoxomicin in biocompatibility: Biodegradable polymeric nanoparticles increase apoptosis in breast cancer cells," European Biotechnology Congress, Dubrovnik, Croatia, 2017
Kucuksayan, ERTAN Et Al. "New combination strategy of doxorubicin and epoxomicin in biocompatibility: Biodegradable polymeric nanoparticles increase apoptosis in breast cancer cells." European Biotechnology Congress , Dubrovnik, Croatia, 2017
Kucuksayan, E. Et Al. (2017) . "New combination strategy of doxorubicin and epoxomicin in biocompatibility: Biodegradable polymeric nanoparticles increase apoptosis in breast cancer cells." European Biotechnology Congress , Dubrovnik, Croatia.
@conferencepaper{conferencepaper, author={ERTAN KÜÇÜKSAYAN Et Al. }, title={New combination strategy of doxorubicin and epoxomicin in biocompatibility: Biodegradable polymeric nanoparticles increase apoptosis in breast cancer cells}, congress name={European Biotechnology Congress}, city={Dubrovnik}, country={Croatia}, year={2017}}